Bio-Rad 연구소, Inc.
| Security | BIO / Bio-Rad Laboratories, Inc. |
| Insider | Eva Anette Engelhardt |
This page shows the track record and history of ENGELHARDT EVA ANETTE
insider trades in Bio-Rad Laboratories, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Eva Anette Engelhardt in BIO / Bio-Rad Laboratories, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Eva Anette Engelhardt in BIO / Bio-Rad Laboratories, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | 550 | 246.5400 | 550 | 246.5400 | 135,597 | 731 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | 2026-05-11 | 4 | ENGELHARDT EVA ANETTE | BIO BIO.B | Bio-Rad A Common Stock | D | 246.5400 | -550 | -136 | 346 | ||||
| 2025-09-09 | 2025-09-06 | 4 | ENGELHARDT EVA ANETTE | BIO BIO.B | Bio-Rad A Common Stock | D | 295.4300 | -413 | -122 | 896 | ||||
| 2025-09-09 | 2025-09-06 | 4 | ENGELHARDT EVA ANETTE | BIO BIO.B | Bio-Rad A Common Stock | D | 1,152 | 1,309 | ||||||
| 2025-07-29 | 2025-07-25 | 4 | ENGELHARDT EVA ANETTE | BIO BIO.B | Bio-Rad A Common Stock | D | 264.1900 | -88 | -23 | 157 | ||||
| 2025-07-29 | 2025-07-25 | 4 | ENGELHARDT EVA ANETTE | BIO BIO.B | Bio-Rad A Common Stock | D | 245 | 245 | ||||||
| 2024-06-17 | 3 | ENGELHARDT EVA ANETTE | BIO BIOB | No securities beneficially owned | D | 0 |
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)
